Bipartisan legislation that would restrict US business with world-leading Chinese biotech companies and their subsidiaries was approved by a House of Representatives committee on Wednesday. The House Committee on Oversight …
Hong Kong stocks extended gains towards an eight-month high after mainland traders returned from a five-day holiday to snap up local shares. Strong travel data and positive calls from a …
Hong Kong stocks dropped, joining a broader retreat in Asian markets, after hawkish comments from a Federal Reserve official tempered bets for an interest-rate cut as early as June this …
Chinese biotechnology companies slumped in Hong Kong by the most in nearly two years, after a US lawmaker proposed a bill to block US companies from doing business with them, …
The stock sell-off in Hong Kong has galvanised some of the biggest companies to rush out their buy-back programmes, with WuXi Biologics, Meituan and Swire Pacific aided by US$2.37 billion …
Hong Kong IPO: WuXi Biologics to spin off contract research, manufacturing unit via US$520 million deal in biotech push WuXi XDC Cayman Inc could raise as much as HK$4.07 billion …